HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rong Lu Selected Research

Fibrosis (Cirrhosis)

1/2019Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis.
1/2017Stachydrine ameliorates pressure overload-induced diastolic heart failure by suppressing myocardial fibrosis.
1/2017The Effects of Guizhi Gancao Decoction on Pressure Overload-Induced Heart Failure and Posttranslational Modifications of Tubulin in Mice.
1/2016Shengmai San Ameliorates Myocardial Dysfunction and Fibrosis in Diabetic db/db Mice.
10/2008A new pentapeptide compound, PLNPK, ameliorates anti-glomerular basement membrane nephritis in Wistar rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rong Lu Research Topics

Disease

66Neoplasms (Cancer)
05/2024 - 11/2002
20Inflammation (Inflammations)
01/2023 - 05/2007
15Infections
04/2024 - 08/2002
15Neoplasm Metastasis (Metastasis)
08/2023 - 04/2004
12Carcinogenesis
01/2021 - 11/2008
12Colonic Neoplasms (Colon Cancer)
01/2020 - 06/2004
12Hepatocellular Carcinoma (Hepatoma)
01/2018 - 04/2004
10Hypertrophy
10/2023 - 05/2013
10Heart Failure
09/2023 - 12/2010
9Breast Neoplasms (Breast Cancer)
09/2022 - 04/2007
8Colitis
10/2021 - 03/2012
8Stomach Neoplasms (Stomach Cancer)
08/2019 - 01/2004
7Cardiomegaly (Heart Hypertrophy)
10/2023 - 05/2013
7Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2019 - 03/2012
7Colorectal Neoplasms (Colorectal Cancer)
08/2017 - 04/2007
6Lung Neoplasms (Lung Cancer)
01/2020 - 01/2006
6Infarction (Infarctions)
01/2019 - 01/2002
5Reperfusion Injury
12/2023 - 02/2002
5Fibrosis (Cirrhosis)
01/2019 - 10/2008
5Carcinoma (Carcinomatosis)
11/2012 - 11/2002
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2023 - 02/2012
4Leukemia
05/2023 - 04/2007
4Bacterial Infections (Bacterial Infection)
11/2019 - 03/2012
4Liver Neoplasms (Liver Cancer)
03/2017 - 04/2002
3Obesity
06/2024 - 05/2015
3Myocardial Infarction
04/2024 - 01/2019
3Squamous Cell Carcinoma of Head and Neck
01/2024 - 01/2022
3Acute Kidney Injury (Acute Renal Failure)
01/2023 - 12/2019
3Chronic Obstructive Pulmonary Disease (COPD)
11/2022 - 01/2021
3Dry Eye Syndromes (Dry Eye Syndrome)
10/2022 - 03/2014
3Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 01/2017
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2019
3Cognitive Dysfunction
11/2020 - 01/2019
3Salmonella Infections (Salmonellosis)
01/2019 - 12/2010
3Adenocarcinoma
11/2018 - 01/2011
3Ischemia
01/2015 - 07/2003
3Melanoma (Melanoma, Malignant)
04/2007 - 01/2006
2Hypertension (High Blood Pressure)
06/2024 - 05/2021
2Body Weight (Weight, Body)
04/2024 - 01/2016
2Pain (Aches)
03/2024 - 01/2018
2Optic Nerve Diseases (Optic Neuropathy)
12/2023 - 08/2023
2Myocardial Ischemia (Ischemic Heart Diseases)
12/2023 - 01/2013
2Ovarian Neoplasms (Ovarian Cancer)
08/2023 - 08/2014
2Osteoporosis
07/2023 - 07/2022
2Rheumatoid Arthritis
07/2023 - 01/2023
2Type 2 Diabetes Mellitus (MODY)
01/2023 - 05/2021
2Hypoxia (Hypoxemia)
01/2023 - 11/2016

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
05/2022 - 09/2004
21Messenger RNA (mRNA)IBA
01/2022 - 02/2002
14Therapeutic UsesIBA
09/2023 - 01/2006
13CytokinesIBA
10/2022 - 05/2010
10stachydrineIBA
04/2024 - 12/2014
10Calcitriol Receptors (Calcitriol Receptor)IBA
10/2021 - 03/2012
10H-Tyr-Ser-Leu-OHIBA
01/2018 - 10/2005
10tripeptide tyroservatideIBA
01/2016 - 01/2006
9CateninsIBA
08/2023 - 03/2012
8Peptides (Polypeptides)IBA
01/2019 - 07/2008
7Vitamin DFDA LinkGeneric
06/2024 - 03/2012
7Biomarkers (Surrogate Marker)IBA
07/2023 - 05/2007
7DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2004
7Histones (Histone)IBA
02/2012 - 06/2004
6Small Interfering RNA (siRNA)IBA
04/2024 - 04/2007
6Immune Checkpoint InhibitorsIBA
09/2022 - 01/2019
6Environmental Pollutants (Pollutants, Environmental)IBA
02/2021 - 01/2018
6MethyltransferasesIBA
01/2019 - 01/2004
5Phenylephrine (Neo-Synephrine)FDA LinkGeneric
10/2023 - 09/2020
5CalciumIBA
02/2020 - 10/2005
5Mitogen-Activated Protein KinasesIBA
12/2010 - 08/2006
5Proliferating Cell Nuclear Antigen (PCNA)IBA
08/2009 - 09/2005
4Cisplatin (Platino)FDA LinkGeneric
01/2024 - 12/2019
4Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 08/2002
4Dextran SulfateIBA
01/2021 - 07/2015
4EnzymesIBA
03/2020 - 07/2008
4CollagenIBA
01/2019 - 04/2002
4Creatine Kinase (Creatine Phosphokinase)IBA
07/2002 - 01/2002
3LipidsIBA
04/2024 - 03/2012
3Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
10/2023 - 01/2022
3Sirolimus (Rapamycin)FDA Link
12/2022 - 07/2008
3Carrier Proteins (Binding Protein)IBA
01/2022 - 12/2004
3AntibodiesIBA
01/2020 - 01/2019
3Tumor Biomarkers (Tumor Markers)IBA
08/2019 - 02/2009
3Claudin-2IBA
01/2019 - 08/2015
3LigandsIBA
01/2019 - 09/2011
3Amino AcidsFDA Link
05/2015 - 01/2006
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2015 - 04/2007
3Phosphotransferases (Kinase)IBA
02/2014 - 09/2010
3Protein Isoforms (Isoforms)IBA
06/2012 - 02/2002
3Folic Acid (Vitamin M)FDA LinkGeneric
01/2011 - 11/2008
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2009 - 04/2007
2Blood Glucose (Blood Sugar)IBA
04/2024 - 01/2016
2Antirheumatic Agents (DMARD)IBA
07/2023 - 01/2023
2Metformin (Glucophage)FDA LinkGeneric
01/2023 - 11/2020
2LipopolysaccharidesIBA
01/2023 - 09/2018
2Fluorouracil (Carac)FDA LinkGeneric
01/2023 - 01/2020

Therapy/Procedure

25Therapeutics
08/2023 - 11/2002
14Drug Therapy (Chemotherapy)
06/2023 - 09/2008
4Decompression
12/2023 - 01/2018
3Radiotherapy
01/2022 - 01/2016
3Aftercare (After-Treatment)
01/2022 - 10/2008
3Heavy Ion Radiotherapy
01/2019 - 01/2016